Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotype of cytochrome P450 CYP2D6 in patients with familial adenomatous polyposis.

Methods and findings in experimental and clinical pharmacology - 1 Apr 2001

Slanar O, Perlík F, Jirásek V

Abstract excerpt

This paper describes an attempt to establish the distribution of the oxidative phenotype of sparteine in patients with familial adenomatous polyposis (FAP). The oxidative polymorphism of sparteine was determined in 30 patients with FAP. One hundred and twenty-six normal subjects were examined as a control group. Subjects with urinary metabolic ratios (MR) greater than 20 (the metabolic ratio of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenomatous Polyposis Coli
Share to Colonic Neoplasms
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Endoscopy, Gastrointestinal

Share to Gene Frequency

Share to Phenotype

Share to Polymorphism, Genetic

Share to Sparteine

Source

Identifiers

PMID: 11523314
DOI: 10.1358/mf.2001.23.3.627948

Genes

FAP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotype of cytochrome P450 CYP2D6 in patients with familial adenomatous polyposis.PMID 11523314Read ↗

Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism.Semantic proximity Read ↗

Glutathione S-transferase Mu phenotype in patients with familial adenomatous polyposis and in unaffected controls.Semantic proximity Read ↗

Enzyme polymorphism on the metabolic O-demethylation of dextromethorphan in a South American population.Semantic proximity Read ↗

A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine.Semantic proximity Read ↗

Genetic polymorphisms of CYP2D6 oxidation in patients with inflammatory bowel disease.Semantic proximity Read ↗

Genetic polymorphisms of drug metabolism.Semantic proximity Read ↗

Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.Semantic proximity Read ↗

Metabolic phenotypes and colorectal neoplasia.Semantic proximity Read ↗

Debrisoquine oxidation polymorphism in patients with chronic inflammatory bowel disease.Semantic proximity Read ↗

Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction.Semantic proximity Read ↗

[Genetic polymorphism in sparteine oxidation--occurrence in healthy volunteers in Slovakia].Semantic proximity Read ↗

The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.